Literature DB >> 17110172

Cluster-crossover design: a method for limiting clusters level effect in community-intervention studies.

Jean-Jacques Parienti1, Oliver Kuss.   

Abstract

The cluster-crossover design can be used for clinical trials comparing two or more interventions in a naturally formed study population, i.e. a cluster. This design differs from that of a crossover study, in that the treatment sequence is allocated at the cluster level. A cluster-crossover study can thus be considered as a cluster-randomized controlled study with additional periodic cluster-randomization(s) or treatment permutation(s) during the study. The data must be analyzed with hierarchical models with random effects in order to allow for different outcome probabilities in each period, cluster and cluster-period. Original data from two published field studies of hospital infection control based on this design are used here to illustrate the impact of different statistical models on the interpretation of the results.

Entities:  

Mesh:

Year:  2006        PMID: 17110172     DOI: 10.1016/j.cct.2006.10.004

Source DB:  PubMed          Journal:  Contemp Clin Trials        ISSN: 1551-7144            Impact factor:   2.226


  22 in total

1.  How statistics can mislead.

Authors:  Kristin L Sainani
Journal:  Am J Public Health       Date:  2012-06-14       Impact factor: 9.308

2.  CORR Insights®: Is There a Difference in Infection Risk Between Single and Multiple Doses of Prophylactic Antibiotics? A Meta-analysis.

Authors:  Gerard P Slobogean
Journal:  Clin Orthop Relat Res       Date:  2019-07       Impact factor: 4.176

3.  The quality of reporting in cluster randomised crossover trials: proposal for reporting items and an assessment of reporting quality.

Authors:  Sarah J Arnup; Andrew B Forbes; Brennan C Kahan; Katy E Morgan; Joanne E McKenzie
Journal:  Trials       Date:  2016-12-06       Impact factor: 2.279

4.  Methodological issues in the design and analyses of neonatal research studies: Experience of the NICHD Neonatal Research Network.

Authors:  Abhik Das; Jon Tyson; Claudia Pedroza; Barbara Schmidt; Marie Gantz; Dennis Wallace; William E Truog; Rosemary D Higgins
Journal:  Semin Perinatol       Date:  2016-06-22       Impact factor: 3.300

5.  Balanced Crystalloids versus Saline in Critically Ill Adults.

Authors:  Matthew W Semler; Wesley H Self; Todd W Rice
Journal:  N Engl J Med       Date:  2018-05-17       Impact factor: 91.245

6.  Balanced Crystalloids versus Saline in Critically Ill Adults.

Authors:  Matthew W Semler; Wesley H Self; Jonathan P Wanderer; Jesse M Ehrenfeld; Li Wang; Daniel W Byrne; Joanna L Stollings; Avinash B Kumar; Christopher G Hughes; Antonio Hernandez; Oscar D Guillamondegui; Addison K May; Liza Weavind; Jonathan D Casey; Edward D Siew; Andrew D Shaw; Gordon R Bernard; Todd W Rice
Journal:  N Engl J Med       Date:  2018-02-27       Impact factor: 91.245

7.  Power and sample size requirements for GEE analyses of cluster randomized crossover trials.

Authors:  Fan Li; Andrew B Forbes; Elizabeth L Turner; John S Preisser
Journal:  Stat Med       Date:  2018-10-08       Impact factor: 2.373

8.  Empirical power and sample size calculations for cluster-randomized and cluster-randomized crossover studies.

Authors:  Nicholas G Reich; Jessica A Myers; Daniel Obeng; Aaron M Milstone; Trish M Perl
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

9.  Protocolized Postextubation Respiratory Support to Prevent Reintubation: A Randomized Clinical Trial.

Authors:  Jonathan D Casey; Erin M Vaughan; Bradley D Lloyd; Peter A Billas; Karen E Jackson; Eric J Hall; Alexandra H Toporek; Kevin G Buell; Ryan M Brown; Roger K Richardson; J Craig Rooks; Reagan B Buie; Li Wang; Christopher J Lindsell; E Wesley Ely; Wesley H Self; Gordon R Bernard; Todd W Rice; Matthew W Semler
Journal:  Am J Respir Crit Care Med       Date:  2021-08-01       Impact factor: 30.528

10.  Extending the I-squared statistic to describe treatment effect heterogeneity in cluster, multi-centre randomized trials and individual patient data meta-analysis.

Authors:  Karla Hemming; James P Hughes; Joanne E McKenzie; Andrew B Forbes
Journal:  Stat Methods Med Res       Date:  2020-09-21       Impact factor: 3.021

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.